RESPIRATORY SYNCYTIAL VIRUS
Clinical trials for RESPIRATORY SYNCYTIAL VIRUS explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY SYNCYTIAL VIRUS trials appear
Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study tests RSV Vaccine's power to shield newborns
⭐️ VACCINE ⭐️ OngoingThis study looks at how well the RSV vaccine (ABRYSVO) given during pregnancy prevents serious RSV lung infections in babies. Researchers will review health records of infants hospitalized with breathing problems in Australia. No new treatments or visits are involved—just data an…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS
Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 11:26 UTC
-
New mRNA vaccine aims to protect older adults from RSV
⭐️ VACCINE ⭐️ OngoingThis study tests a new mRNA vaccine (ABO1105) for respiratory syncytial virus (RSV) in 420 healthy adults aged 50 and older. Participants receive one injection of either a low or high dose of the vaccine or a placebo. The goal is to see how well the vaccine triggers an immune res…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS
Phase: PHASE2 • Sponsor: Suzhou Abogen Biosciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 11:23 UTC
-
New mRNA shots aim to protect toddlers from two common winter viruses
⭐️ VACCINE ⭐️ OngoingThis study tests two new mRNA vaccines in toddlers aged 5 to 24 months. One vaccine targets both RSV and hMPV, while the other targets only RSV. The main goal is to check if the vaccines are safe and help the body build defenses against these viruses that can cause serious breath…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS
Phase: PHASE1 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 11:09 UTC
-
New mRNA vaccine takes on RSV in early human trial
⭐️ VACCINE ⭐️ OngoingThis early-stage trial tests a new mRNA vaccine (ABO1105) for respiratory syncytial virus (RSV) in 96 healthy adults aged 18 and older. The main goal is to check the vaccine's safety and how well the body's immune system responds. Participants receive one injection at different d…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS
Phase: PHASE1 • Sponsor: Suzhou Abogen Biosciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated May 22, 2026 13:52 UTC
-
Could a shot during pregnancy shield babies from RSV?
⭐️ VACCINE ⭐️ OngoingThis study tests an experimental mRNA vaccine (mRNA-1345) against RSV in 360 pregnant women. The goal is to see if the vaccine is safe for mothers and their babies, and whether it can pass protection to infants after birth. Participants receive either the vaccine or a placebo bet…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS
Phase: PHASE2 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 19, 2026 11:47 UTC
-
Pregnancy vaccine shields infants from RSV — real-world study launched
⭐️ VACCINE ⭐️ OngoingThis study looks at how effective the ABRYSVO® vaccine is when given to pregnant women to protect their babies from RSV, a serious respiratory virus. Researchers will review medical records of infants up to 9 months old who were hospitalized with breathing problems. The goal is t…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS
Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated May 04, 2026 16:18 UTC